Evidence map›Paper›PMID 25665868›Full record

ArticleMicrovascular research2015

ID3 contributes to the acquisition of molecular stem cell-like signature in microvascular endothelial cells: its implication for understanding microvascular diseases.

Jayanta K Das, Norbert F Voelkel, Quentin Felty

Open access · greenAbstract read
In one paragraph

Article in Microvascular research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Comprehensive phenotyping of endothelial cells using flow cytometry 2: Human.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jayanta K DasDepartment of Environmental & Occupational Health Florida International University, Miami, FL, USA.
Norbert F VoelkelPulmonary and Critical Care Medicine Division and Victoria Johnson Center for Obstructive Lung Diseases, Virginia Commonwealth University, Richmond, VA, USA.
Quentin FeltyDepartment of Environmental & Occupational Health Florida International University, Miami, FL, USA. Electronic address: Feltyq@fiu.edu.
Florida International University · USVirginia Commonwealth University · US

Funding

Estrogen-induced Pyk2 signaling in the abnormal growth of vascular cellsSC3GM084827 · NIGMS · FLORIDA INTERNATIONAL UNIVERSITY · PI FELTY, QUENTIN · 2010 to 2013
$428k
NIGMS NIH HHS 1SC3GM084827-01A1NIGMS NIH HHS SC3 GM084827
6 · The paper itself

Abstract

While significant progress has been made to advance our knowledge of microvascular lesion formation, yet the investigation of how stem-like cells may contribute to the pathogenesis of microvascular diseases is still in its infancy. We assessed whether the inhibitor of DNA binding and differentiation 3 (ID3) contributes to the acquisition of a molecular stem cell-like signature in microvascular endothelial cells. The effects of stable ID3 overexpression and SU5416 treatment - a chemical inducer of microvascular lesions, had on the stemness signature were determined by flow cytometry, immunoblot, and immunohistochemistry. Continuous ID3 expression produced a molecular stemness signature consisting of CD133(+) VEGFR3(+) CD34(+) cells. Cells exposed to SU5416 showed positive protein expression of ID3, VEGFR3, CD34 and increased expression of pluripotent transcription factors Oct-4 and Sox-2. ID3 overexpressing cells supported the formation of a 3-D microvascular lesion co-cultured with smooth muscle cells. In addition, in vivo microvascular lesions from SuHx rodent model showed an increased expression of ID3, VEGFR3, and Pyk2 similar to SU5416 treated human endothelial cells. Further investigations into how normal and stem-like cells utilize ID3 may open up new avenues for a better understanding of the molecular mechanisms which are underlying the pathological development of microvascular diseases.

Indexed as

MicrocirculationAC133 AntigenAnimalsAntigens, CDAntigens, CD34Cell CycleCell DifferentiationCell SeparationEndothelial CellsFlow CytometryGlycoproteinsHumansIndolesInhibitor of Differentiation ProteinsNeoplasm ProteinsPeptidesAC133 AntigenAntigens, CDAntigens, CD34FLT4 protein, humanGlycoproteinsID3 protein, humanId3 protein, ratIndolesInhibitor of Differentiation ProteinsNeoplasm ProteinsPeptidesPROM1 protein, humanProm1 protein, ratPyrrolesSemaxinibVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-3Endothelial cellsID3Microvascular lesionSemaxanibStemnessSU5416

Identifiers

PMID25665868
PMCPMC4361266
OpenAlexW2063855302

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.